Streetbeat News

Regulatory

DJT

SPY

The U.S. Supreme Court has declined Robert F. Kennedy Jr.'s request to remove his name from the presidential ballot in Wisconsin and Michigan. Kennedy, a former independent presidential candidate and Trump supporter, sought to withdraw from these states' ballots.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:45 pm

LYV

Oasis promoters, including Live Nation Entertainment Inc (NYSE:LYV), are canceling over 50,000 tickets for their UK reunion tour to combat scalping. The canceled tickets will be redistributed at face value through Ticketmaster. This move addresses the issue of unauthorized resales, which have seen tickets priced exorbitantly on platforms like Viagogo and StubHub. Despite the controversy, the promoters are committed to ensuring fair ticket distribution.

Portfolio Pulse from Franca Quarneti

October 29, 2024 | 8:37 pm

SPY

The fiscal plans of Donald Trump and Kamala Harris for the 2024 U.S. presidential election could significantly increase the national debt. Trump's plan may add $7.75 trillion, while Harris's could add $3.95 trillion by 2035. These plans are impacting financial markets, with rising Treasury yields and potential inflationary pressures. Gold prices, tracked by SPDR Gold Trust (NYSE:SPY), have reached record highs, indicating market anticipation of policy shifts.

Portfolio Pulse from Piero Cingari

October 29, 2024 | 8:17 pm

MDLZ

Mondelēz International is set to acquire a majority stake in the Chinese cake and pastry maker Evirth. The deal is expected to close in Q4 2024, pending regulatory approval. Mondelēz incurred $2 million in acquisition costs last quarter.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:10 pm

CTRE

ENSG

The Ensign Group, Inc. is expanding its operations by adding eight skilled nursing facilities in Tennessee and one in Alabama. Six of these will be jointly owned with CareTrust REIT, Inc. and three will be purchased by Ensign's subsidiary, Standard Bearer Healthcare REIT, Inc. The transaction is pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:06 pm

SPRO

Trading for SPRO was halted at 4:00:11 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:00 pm

TVGN

Tevogen Bio has regained compliance with Nasdaq's minimum bid price requirement without a reverse stock split, maintaining a closing price of $3.05.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 7:37 pm

ONCT

Oncternal Therapeutics has been granted a U.S. patent for 'Selective Androgen Receptor Degrader Ligands and Methods of Use Thereof' aimed at treating prostate cancer. This patent could enhance Oncternal's intellectual property portfolio and potentially impact its market position in cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 7:17 pm

ABBV

AbbVie's small cell lung cancer treatment, an antibody drug conjugate, has been granted FDA orphan designation. This designation is significant for AbbVie as it can provide benefits like market exclusivity and tax credits.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 7:12 pm